Methyl 2-(bromomethyl)-5-cyanobenzoate, 95.0%, 250mg

2-Methyl-cyclopropanecarbonyl chloride, 95.0%, 1g

2-(Dimethylamino)ethyl Acrylate (stabilized with MEHQ)>98.0%(GC)25g

4-(((2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)amino)benzoic acid, 95.0%, 100mg

N-Succinimidyl 7-Methoxycoumarin-3-carboxylate>98.0%(HPLC)(N)100mg

N-Methylmaleic Acid Monoamide>98.0%(T)25g

Methyl alpha-bromo-2-chlorophenylacetate, 95.0%, 10g

2-((5-Chloroquinolin-8-yl)oxy)-N,N-diethylethanamine dihydrochloride, 98.0%, 100mg

3-Chloro-2,2-dimethylpropan-1-ol, 95.0%, 25g

2-Amino-3-(trifluoromethoxy)benzoic acid, 97.0%, 1g

Bicyclo[3.1.0]hexan-2-one, 98%, 250mg

(1-Isopropyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 10g

GC capillary column ROTI®Cap-1 MS, 60 m, 0.32 mm, 0.25 µm, 1 Piece(s)